TFF3 and gastric cancer: ROC curve analysis showed that serum TFF3 had 80.0% of positive predictive value, 80% sensitivity and 72.4% specificity, with an AUC of 0.844 and optimal cut-off (8.98 ng/ml) when gastric cancer patients were separated from healthy individuals.